Hempworx

About Hempworx

At Hemp Worx,  our CBD products utilize the full spectrum Cannabis plant mixed with Hemp Seed oil. Not all hemp is created equal. Our CBD Oil is made from NON-GMO, PESTICIDE FREE, CO2 Extracted Hemp Oil.

In our experience, a full spectrum plant gives the Endocannabinoid system (ECS) the full cannabinoid profile of CBD, CBG, CBC, CBN, in order to substantiate the health claims. We have over 120 cannabinoids in our CBD formulas which perfectly inhibits the CB2 receptors in the body. While our competitors have gone the most cost effective route and have skimped on ingredients & formula, we are 100% committed to providing the most potent, most pure, and most effective Hemp products on the market. Due to our farming, science, and unique formulations, the HempWorx products are trusted by hundreds of thousands of customers around the globe!

How does CBD work in the human body?

CBD or cannabidiol is the main active compound in hemp, and unlike THC, it is not psychoactive, so it doesn’t make people high. As you know, inside the human body there’s the endocannabinoid system, with receptors spread throughout the brain and body.

Phytocannabinoids 

With our HempWorx line, our products utilize a Full Spectrum CBD formulated with Hemp Seed Oil. For the first time in 1964, CBD isolation was reported and it was the beginning of cannabinoid synthesisation. Originally, this synthesis started on CBG, but since CBG is present in most of the Cannabis types in small amounts, the majority of the research was concentrated on THC and CBD. Besides the Cannabinoids that are naturally occurring in nature, pharmaceutical companies have synthesized cannabinoid compounds in order to market leading drugs in the pharmaceutical market. Some of these chemically modified drugs do not have psychoactive effects, but retain some of the health benefits from the cannabinoid properties. However, some of these synthetic drugs can have a life-threatening adverse effect, or cause other issues in the human body. Phytocannabinoids, on the other hand, have been used for many years, and no life-threatening side effects have ever been reported. 

Find out More HERE

Pure Hemp

About Pure Hemp

Pure Hemp offer a wide range of CBD products and have quickly expanded there line to include cooking supplies, sprays, and even protein powders.

Find out more HERE

CBD Full Spectrum - 1500mg Natural Flavor
CBD Full Spectrum Oil


CBD Syrup - Blueberry 200mg
CBD Syrup
Swapple Cartridges - 200mg
Swapple Cartridges
CBD Lollipop – Sour Apple 50mg
CBD Lollipops
CBD Gummies - Cherry Bomb 300mg
CBD Gummies
CBD Energy & Focus Oral Spray - 60mg
CBD Oral Spray
CBD Extract Capsules - 750mg
CBD Extract Capsules
Salted Caramel CBD Spray For Weight Loss
CBD Weight Loss Spray
CBD Sleep Spray - 60mg
CBD Sleep Spray
CBD Freeze Cold Therapy Pain Rub - 50mg
CBD Freeze Pain Rub
CBD Pet Food Spray - 100mg
CBD Pet Spray


Collagen Retinol + CBD Revive Cream
CBD Revive Cream
CBD Pet Treats - 150mg
CBD Pet Treats
CBD Under Eye Cream
CBD Under Eye Cream
CBD Protein Powder - Chocolate 300mg
CBD Protein Powder
CBD Honey - 250mg
CBD Honey
Super Strength Salve -  150mg
Super Strength Salve
Pain Relief Roll On Gel - 100mg
CBD Pain Relief Roll On
CBD Ultra Body Moisturizing Butter - 20mg
CBD Body Butter
CBD Infused Lip Balm - Peppermint
CBD Infused Lip Balm
Lavender CBD Bath Bomb - 25mg
CBD Bath Bomb
Anti-Aging Cream with Apple Stem Cells
CBD Anti Ageing Cream
CBD Anti-Stress Pet Spray - 60mg
CBD Anti Stress & Calming Pet Spray
CBD Joint Pain Pet Spray - 60mg
CBD Joint & Pain Support Pet Spray
Pet Shampoo - 20mg
CBD Pet Shampoo
CBD Health & Wellness Pet Spray - 60mg
CBD Health & Wellness Pet Spray
Skincare Facial Cleanser
CBD Facial Cleanser
Skincare Facial Toner
CBD Toner
AM-PM Cream
CBD AM-PM Cream
Olive Oil - 250mg
CBD Olive Oil
Night Skin Rejuvenator Cream
CBD Night Cream
Tattoo Aftercare Cream
CBD Tattoo Aftercare Cream
Vegetable Oil - 250mg
CBD Vegetable Oil
CBD Chili Oil - 250mg
CBD Chilli Oil
Balsamic Vinaigrette  - 250mg
CBD Balsamic Vinagrette
CBD Ground Coffee - Medium Roast - 90mg
CBD Ground Coffee
CBD Cold Brew Coffee - 20mg
CBD Cold Coffee
CBD Double Chocolate Cookies - 200mg
CBD Cookies
CBD Milk Chocolate Bar - 400mg
CBD Choclate

Growing Elite Marijuana

The Ultimate Guide to The World’s Best Marijuana Growing System

Unlike other grow bibles, this is a full tutorial that cuts to the chase.

It’s a step-by-step guide to getting flawless grow and incredibly potent bud every time.

It breaks down every process in order, telling you exactly what you need to succeed.

By the end of the book, you’ll know exactly what you need to grow the perfect bud—from seeds, strains, lighting, soil to harvesting.

Find out more HERE

how much yield can I produce growing

Free Bonus #1 – The Cannabis Care Manual

weed plant problems


Free Bonus #2 – The Marijuana Growing Quick-Start Guide

grow forums

Free Bonus #3 – The Stoner’s Cookbook

how to make your own cannabutter
marijuana smoking recipes

Free Bonus #4 – The Ultimate Strain Guide

best marijuana grow book for beginners

Free Bonus #5 – Build Your Own Homemade Smoking Devices

homemeade smoking devices

Free Bonus #6 – Ganja Etiquette

ganja girls smoking

Free Bonus #7 – Deadly Marijuana Growing Mistakes

top growing mistakes marijuana

Free Bonus #8 – Marijuana Security Blackbook

marijuana privacy security

Free Bonus #9 – Exclusive 420 Membership Club Card

marijuana club card

Green Cultured

About Green Cultured

The cannabis industry changes constantly. That’s why we’re here. We offer a variety of training solutions to help you meet your goals. With the help of our Subject Matter Experts and training technologies, we stay up-to-date on all the latest trends and changes in the cannabis industry, so you don’t have to. Everyone has unique training objectives, so a one-size-fits-all training solution just won’t cut it for your needs.

Based in Denver, Colorado, founded in 2012 ‘at the heart’ of the cannabis industry and we are a training provider for ‘all things’ in the cannabis industry. It’s a place where you can learn how to train like a pro, connect with industry experts, and get the strategies and tools you need to grow your business to new heights.

We’ve become one of the cannabis industry’s most TRUSTED voices by sharing the best of what works in training. Every organization has unique business objectives, so a one-size-fits-all training solution just won’t cut it for your needs. 

Our ‘product’ is a plug-and-play total training solution that is unlike any other options in the cannabis industry. We manage all the ‘moving parts’ and removed the guesswork from creating a training solution to help make rapid business growth available to EVERYONE in your organization.

If you’re operating in the cannabis industry or are a government entity, we can help you to create an effective training solution that improves learner performance, reduces risk, and increases the bottom-line of your operations. Best of all, we know our advice works because we actually DO this stuff every day.

The cannabis industry changes constantly. That’s why we’re here. We established Green CulturED as the ‘answer’ for business owners who are DISSATISFIED with the training options available in the cannabis industry.

As a total eLearning solution provider, we’re a smart, innovative company helping others in the cannabis industry SOLVE their training needs. Leave the heavy lifting to us! Bottom-line, we can handle all-things cannabis that you need, now and tomorrow.

Find out more HERE

Cannabis Cultivation
Cannabis Cultivation
Cannabis Chemistry
Cannabis Chemistry
Medical Aspects
Medical Aspects
Retail Dispensary
Retail Dispensary
Industry Certifications
Industry Certifications
Government Compliance
Government Compliance
Cannabis Studies
Cannabis Studies

CBD Gum

About CBD Gum

Purchasing Cannabidiol (CBD) products online, that are right for you and your health, is a big decision. After all, who knows more about what your body needs than you? Looking around the web to buy CBD oil products can be daunting, especially since the industry is so young, and wrought with misinformation.

This is why CBDGum.NetworkofHemp.com was created: to provide to you the best opportunity to improve your health with all natural, non-GMO, and pesticide-free hemp based CBD rich products. Harsh chemicals or solvents ARE NOT USED when obtaining the high CBD hemp oil found in the products we sell on this site. Supercritical Fluid Extraction is the method of choice, which utilizes highly pressurized CO2 within a closed system under cold temperatures to preserve the nutritional profile of the hemp plant, passing all of that nutrition on to you.
Buy CBD Oil From Reputable Growers And Manufacturers
Currently, companies involved in the production of hemp and cannabis varieties do not have a single source for genetic purity, consistency and cannabinoid profiles. Just as a brother and sister are made from the same parents, their genetic make up has slight enough differences to create two unique and amazing people. And that same principle goes for the hemp plant. Using top quality genetics, in conjunction with the knowledge of multi-generational hemp farmers, we now offer you access to premium CBD Rich Hemp Oil products shipped directly to your door. You can rest assured when you buy CBD oil products from us, you will receive the highest quality with the fastest shipping times on the net.

At this time, we have many product lines that contain high quality hemp CBD oils, and we are adding more all the time:

Find out more HERE

CBD Beverages
CBD Beverages
CBD Capsules
CBD Capsules

CBD Edibles
CBD Edibles
CBD Tinctures And Drops
CBD Tinctures and Drops
CBD Topicals
CBD Topicals
CBD Vaporizers
CBD Vaporizers
High CBD Hemp Oil
High CBD Hemp Oil
Terpene Infused Products
Turpene Infused Products

CBDfx

CBDfx is proud to offer the highest quality, full spectrum CBD products on the market. Their priority is to give everyone access to the remarkable benefits of CBD with the widest selection of high quality, organically grown CBD products. What is CBD? They provide the best CBD Vape Additives, CBD Vape Oil, CBD Dabs and CBD Tinctures. Do you like CBD edibles? Try our CBD Drinks, CBD Capsules and CBD Gummies! Regardless of your preferred method of taking CBD, you can rest assured that CBDfx offers the best CBD products available on the market

Find out more HERE

CBD Tincture Oil
CBD Vape Juice

Treating depression with cannabinoids

use

Article by: Kurt Blaas; Lindengasse 27/10, 1070 Vienna, Austria – drblaas@blowdoc.at

Abstract
Although a variety of drugs are available for the treatment of depression, therapy is not effective in all cases and finding alternative options is desirable. Results from animal studies, anecdotal experience reported by patients using cannabis and observations from clinical studies where cannabinoids were used in serious diseases suggest an anti-depressive potential of cannabinoid receptor agonists. From 2003 to 2006, 75 patients suffering from depression, stress and burnout syndrome were successfully treated in a practice for general medicine with the cannabis ingredient dronabinol, alone or in combination with other antidepressants. Two case studies will be presented. The presented observations suggest that dronabinol has an antidepressive potential that can
readily be used in medical practice. Key words: Depression, burnout, cannabinoid, cannabis, dronabinol.

Introduction
In several prospective studies, consumption of cannabis was associated with an increased risk of developing depression and anxiety, particularly when cannabis had
been used during adolescence [1,2]. There appears to be less evidence for a correlation between depression and cannabis use during adulthood [3,4]. On the other
hand, patients have, in numerous surveys and interviews, reported anti-depressant and anxiolytic effects of cannabis [5-11]. Patients suffering from a range of chronic illnesses have reported that they use cannabis not only to mitigate physical symptoms, such as pain, nausea and lack of appetite, but also to improve general well-being and to mitigate anxiety and depression [8- 10,12]. In several clinical studies, during which subjective
parameters were monitored, cannabinoids not only improved physical symptoms but also improved wellbeing and produced measurable antidepressant effects
[13-15]. A study by Musty (2002) with healthy volunteers, smoking cannabis showed a positive correlation with the ratings on a scale of depression (MMPI), indicating an antidepressant effect [16]. These indications of a therapeutic potential of symptoms of depression encouraged the author to start administering dronabinol to select patients suffering from depression.

Experiences in Medical Practice

The author operates a practice for general medicine in downtown Vienna, where a large population of younger people lives and works. In the late 1990s I began administering dronabinol to individual younger patients, who were dissatisfied with available antidepressants because of side effects or lack of effectiveness. In Austria, the active ingredient of cannabis has been available for medical therapy since 1998. The
majority of these early patients, who suffered from a reactive depression or burnout syndrome, was well aware of the therapeutic potential of cannabis and considered a trial with dronabinol reasonable. Between 2003 and 2006 some 250 patients who suffered from a wide range of illnesses were treated in my practice with dronabinol. Some 75, or 30%, of them suffered from depression, a sense of being overwhelmed or from burnout syndrome. The initial dose of 2.5 mg dronabinol in capsules was raised, over a period
of several days, to generally 5 or 7.5 mg per day. For almost 80% of the patients, use of the medication cor- Blaas Cannabinoids Œ Vol 3, No 2 Œ June 22, 2008 9
related with swift improvement of the depressed mood or the sense of being overwhelmed. Only 20% of patients did not experience any significant mood brightening. To that group a combination therapy of dronabinol and a selective serotonin reabsorption inhibitor (SSRI), such as fluoxetine hydrocholoride at a dose of
20 mg per day or a serotonin noradrenalin reabsorption inhibitor (SNRI), such as milnacipran at 50 mg per day, was administered. That therapy generally resulted in
rapid and satisfactory improvement of depression and the lack of drive.
Side effects were generally low. Effective daily doses of dronabinol ranged generally from 7.5 to 12.5 mg per day. Only few patients required a higher dosage, generally those also suffering from a sleeping disorder.

Case Reports

In the following two exemplary cases from a large number of successful treatments are presented.

Case 1

Ms. H. came to my practice six years ago, at the age of 48. She had a long psychiatric record with episodes of depression and the abuse of alcohol and drugs, particularly of benzodiazepines. A former teacher, she is now retired but continues to work as an actress. At the onset of the therapy the patient was in a difficult situation. Her father had recently passed away; she was highly depressed, sometimes even suicidal. Heavy
abuse of drugs, such as oxazepam, and of alcohol further complicated her situation. Following an extensive discussion a treatment with oral dronabinol of 5 – 7.5
mg per day was started. After 6 years of using dronabinol Ms. H. is now very
experienced with the use of the drug. Depending on her symptoms, she takes between 2 and 4 capsules of 2.5 mg per day. She is no longer addicted to benzodiazepines and does currently not drink alcohol. As supplementary therapy she takes 2.5 mg per day of olanzapin (an atypical neuroleptic), 25 mg of venlafaxin (an SNRI) and, if needed, trazodon, SSRI. She reports that the dronabinol therapy has improved her quality of life
significantly. She feels more stable than before and the chronically reoccurring episodes of depression are less severe. Her speed of reaction when operating a vehicle
is impaired. Before extended car trips she has thus periodically suspended dronabinol for typically one week, which has resulted in psychological withdrawal symptoms.

Case 2

Ms. F. first visited our practice at the age of 22 where she received treatment over a 12-month period. At that time, the patient suffered from tress related headaches,
migraine, asthma, neurodermatitis and an instable emotional personal disorder. Most prominent was an acute depressive syndrome, for which Ms. F. had already
received treatment in the psychiatric clinic at Vienna General Hospital.
After repeatedly dropping out of school and frequent job changes the patient tried, despite a lack of family contacts, to improve her dismal social and physical
conditions. She was also rather unhappy with her having to consume up to ten prescription medications. In addition to anti-depressants, such as fluoxetine and
mianserin, neuroleptics, such as prothipendyl, sedatives and anti-allergic agents, such as hydroxyzine, NSAR, such as diclofenac, proton pump inhibitors, such as
rabeprazole, analgesics, such as propyphenazone and tramadol, she daily consumed anti-asthmatics, such as terbutaline sulfate as prescribed by several other physicians.
Because the patient did not want to continue this multidrug treatment she came to our practice in search for a more simple and natural treatment, involving no more
than two drugs. Primary objective of the treatment was to improve her acutely depressive condition, which had not improved despite the use of multiple drugs. Following an extensive consultation the patient opted for a monotherapy with dronabinol. After several days the initial dose of 2.5 mg was raised to 7.5 mg daily. After
several days of treatment we observed a significant improvement of her depressive condition and of the concurrently occurring illnesses. During the first month of therapy the daily dronabinol dose was raised to 10 mg and 12 month after starting
her therapy the physical and psycho-social condition of the patient had stabilized at that dose. Subsequently, the patient resumed relationships with her family, relocated to a different state and left our practice.

Conclusions

In summary, the experience presented here suggests that general practitioners are able to treat a large number of patients suffering from depression and burnout syndrome without significant complications. Most patients were not reimbursed for dronabinol by their health insurance, unlike for patients with physical illnesses, such as cancer or multiple sclerosis, where the local health insurance in Vienna pays for nearly 60% of
the cost of dronabinol. These findings agree with the results from patient interviews, observations from clinical studies on the impact of cannabinoid use on mood and the results from animal experiments. In the latter, exogenous cannabinoid receptor agonists [17,18] as well as the inhibition of the deactivation of the endocannabinoid anandamide [18,19] resulted in antidepressant effects. To date no clinical studies have studied primarily the effectiveness of cannabinoids for the treatment of depression. In my opinion, such studies are desirable and promising. References 1. Hayatbakhsh MR, Najman JM, Jamrozik K, Mamun AA, Alati R, Bor W. Cannabis and anxiety and depression in young adults: a large prospec- Original article 10 Cannabinoids Œ Vol 3, No 2 Œ June 22, 2008 tive study. J Am Acad Child Adolesc Psychiatry 2007;46(3):408-417.
2. Wittchen HU, Fröhlich C, Behrendt S, Günther A, Rehm J, Zimmermann P, Lieb R, Perkonigg A. Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. Drug Alcohol Depend 2007;88 Suppl 1:S60-70. 3. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007;370(9584):319-28.
4. Harder VS, Morral AR, Arkes J.Marijuana use and depression among adults: Testing for causal associations. Addiction 2006;101(10):1463-72. 5. Joy JE, Watson SJ, Benson JA (eds): Marijuana and Medicine: Assessing the Science Base. Institute of Medicine. Washington DC: National Academy Press, 1999. 6. Gieringer D. Medical use of cannabis: experience
in California. In: Grotenhermen F, Russo E, eds. Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential. Binghamton/New York: Haworth Press, 2002. 7. Schnelle M, Grotenhermen F, Reif M, Gorter RW. Ergebnisse einer standardisierten Umfrage zur medizinischen Verwendung von Cannabisprodukten im deutschen Sprachraum. Forsch Komplementärmed 1999;6(Suppl 3):28-36.
8. Prentiss D, Power R, Balmas G, Tzuang G, Israelski DM. Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. J Acquir Immune Defic Syndr 2004;35(1):38-45. 9. Amtmann D, Weydt P, Johnson KL, Jensen MP,
Carter GT. Survey of cannabis use in patients with amyotrophic lateral sclerosis. Am J Hosp Palliat Care 2004;21(2):95-104. 10. Woolridge E, Barton S, Samuel J, Osorio J,
Dougherty A, Holdcroft A. Cannabis use in HIV for pain and other medical symptoms. J Pain Symptom Manage 2005;29(4):358-67. 11. Ware MA, Adams H, Guy GW. The medicinal use of cannabis in the UK: results of a nationwide survey. Int J Clin Pract 2005;59(3):291-5. 12. Page SA, Verhoef MJ, Stebbins RA, Metz LM, Levy JC. Cannabis use as described by people with multiple sclerosis. Can J Neurol Sci 2003;30(3):201-5.
13. Regelson W, Butler JR, Schulz J, Kirk T, Peek L, Green ML, Zalis MO. Delta-9-tetrahydrocannabinol as an effective antidepressant and appetitestimulating agent in advanced cancer patients. In: Braude MC, Szara S, eds. Pharmacology of marihuana. Vol 2. Raven Press, New York 1976. S. 763-776. 14. Beal JE, Olson R, Laubenstein L, Morales JO, Bellman P, Yangco B, Lefkowitz L, Plasse TF, Shepard KV. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage 1995;10(2):89-97. 15. Maida V, Ennis M, Irani S, Corbo M, Dolzhykov M. Adjunctive nabilone in cancer pain and symptom management: a prospective observational
study using propensity scoring. J Support Oncol 2008;6(3):119-24. 16. Musty RE. Cannabinoid therapeutic potential in motivational processes, psychological disorders
and central nervous system disorders. In: Onaivi ES, Hrsg. Biology of Marijuana. From Gene to Behaviour. London/New York: Taylor & Francis, 2002. 17. Bambico FR, Katz N, Debonnel G, Gobbi G. Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J Neurosci 2007;27(43):
11700-11. 18. Hill MN, Gorzalka BB. Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test. Eur Neuropsychopharmacol 2005;15(6):593-9. 19. Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG, Debonnel G, Duranti A, Tontini A, Tarzia G, Mor M, Trezza V, Goldberg SR, Cuomo V, Piomelli D. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A 2005;102(51):18620-5.